Hardman & Co

Avacta Group Affimer Drug Conjugates a reality

Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology

Hardman & Co

Advanced Oncotherapy Consolidating market

Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in

Hardman & Co

Collagen Solutions Targeting long-term sustainable growth

Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have

Hardman & Co

Diurnal Group Alkindi®: On route to Europe

Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead candidates are targeted at rare diseases with unmet medical

Hardman & Co

ValiRx Plc Clinical efficacy of VAL401

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Hardman & Co

genedrive plc Remodelled for growth

genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care/need molecular diagnostics and biomarkers. Its Genedrive® in vitro diagnostic testing platform is at the forefront of this technology, offering a

Hardman & Co

Evgen Pharma Funded to the end of Phase II trials

Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways

Hardman & Co

Hardman Agribusiness: Jatropha Sector Review

Jatropha curcas, traditionally an undomesticated hedging plant with secondary utility as a source of oil, came to prominence when it was proposed as a feedstock for biofuel during an earlier

Diversified Energy Company plc
Diversified Energy CEO Rusty Hutson discusses the Maverick Natural Resources acquisition and its impact on growth, margins, and sustainability goals.
Cerillion
In an exclusive interview with DirectorsTalk, Cerillion plc CEO Louis Hall discusses the $11.4 million telecom contract and its impact on the company's growth strategy.
Pan African Resources
Discover the success behind Pan African Resources plc and its outperformance as discussed by Gervais Williams, Co-Fund Manager of Diverse Income Trust plc.
One Health Group plc
In an exclusive interview, One Health Group plc CEO Adam Binns discusses the company's partnership with the NHS, operational growth, and future plans.
Ilika plc
In an exclusive interview, Ilika plc CEO Graeme Purdy discusses progress with Stereax & Goliath, exciting technical milestones, and competition with peers.
Arbuthnot Banking Group plc
Gervais Williams discusses Arbuthnot Banking Group plc's success and potential growth in an exclusive interview with DirectorsTalk.
Discover the latest trends in commercial real estate investment, from shifting market landscapes to emerging opportunities in private credit financing.
Volta Finance
Discover the allure of Collateralized Loan Obligations (CLOs) and how they offer high yields and structured returns to savvy investors in today's market.
Fidelity China Special Situations
China's AI sector is booming thanks to DeepSeek's breakthrough, attracting investment and reshaping the tech rivalry with the U.S. Learn more here.
Fidelity Special Values
The British Pound is gaining momentum against the US Dollar, with potential for a test of the 2025 high. Trade tensions and central banks drive volatility.
Fidelity European Trust
European markets saw a lift driven by key earnings reports, with notable movements in sectors like automobiles and financial services. Read more here.
Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.
Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.
SAE Renewables (LON:SAE) advances energy ambitions with £1.3M payment for Uskmouth BESS project. Analyst sees positive impact on future projects.
hVIVO plc
hVIVO plc achieves milestone with £3.2 million hLAB contract, showcasing growth in laboratory services. Read about the company's latest achievement here.
Greggs
Greggs plc (LON:GRG) shines in tough market conditions, delivering solid FY24 results with revenue of £2,014 million and strong growth.